Methicillin-resistant Staphylococcus Aureus Drugs Market Trends

Growth Drivers

• Surge in geriatric population - One in six individuals on the entire globe is predicted to be 60 years of age or beyond by 2030. Currently, there are an estimated 1.4 billion people over the age of 60, up from 1 billion in 2020. Hence, with this, the cases of MRSA are also growing in older people. Since MRSA is resistant to common antibiotics, it poses a significant risk to elderly people owing to the high intake of antibiotics.
  This is high, particularly in institutional settings where seniors are already at a higher risk of mortality from the illness.Furthermore, the immune of older people is also weak which makes them highly prone to this infection. Thus, with the growing old age population, methicillin-resistant staphylococcus aureus drugs market will generate significant revenue.
• Rising adoption of AI in healthcare - AI is proving its importance in the healthcare sector. For instance, through the application of deep learning, a form of artificial intelligence, MIT researchers have identified a class of drugs capable of eliminating a drug-resistant bacterium that accounts for over 9,000 fatalities annually in the US. Hence, the use of AI has also shown great accuracy in screening tests for MRSA.
  A particular screening test is frequently used to detect patients who possess MRSA. Clinicians may find it useful to use MRSA detection to identify individuals who may potentially spread the infection to other patients as well as to choose the best medicines.
  However, real-time information is unable to obtain, using the widely utilized culture screening method for MRSA since it takes several days to receive the result. Therefore, it would be extremely important and impactful in the clinical situation to accurately and promptly predict whether MRSA is present in patients on mechanical ventilation or not. Machine learning techniques are beneficial for clinical decision assistance in infectious diseases.

Challenges

• Lack of trained professionals in the field of methicillin-resistant staphylococcus aureus drugs - Accurate interpretation of findings is necessary for methicillin-resistant staphylococcus aureus drugs procedures, and researchers need to understand which analyses to perform and how to connect them to the experiment's main goal. Therefore, an adequate understanding of the relevant technology is necessary for the researcher to conduct successful research experiments.
  As such, the MRSA identification procedure needs to be carried out by highly qualified individuals. The majority of lab professionals lack sufficient training regarding the newest innovations in lab equipment and their advantages. Furthermore, there is a dearth of skilled workers capable of operating highly developed diagnostic equipment.
• High Cost of Testing negatively influence the market
• Lack of Awareness About MRSA Infection